Translating noninvasive molecular responses into clinical reality for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1038/s41571-020-00450-4
Published Online: 2020-11-09
Published Print: 2021-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Murray, Joseph C.
Anagnostou, Valsamo
Text and Data Mining valid from 2020-11-09
Version of Record valid from 2020-11-09
Article History
First Online: 9 November 2020
Competing interests
: V.A. receives research funding from Bristol–Myers Squibb. J.C.M. declares no competing interests.